Journal
BLOOD
Volume 115, Issue 17, Pages 3453-3462Publisher
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2009-10-246694
Keywords
-
Categories
Funding
- National Institutes of Health
- Burroughs Welcome Fund
- Leukemia & Lymphoma Society
- Howard Hughes Medical Institute
- Harvard Stem Cell Institute
Ask authors/readers for more resources
Fanconi anemia (FA) is a genetically heterogeneous, autosomal recessive disorder characterized by pediatric bone marrow failure and congenital anomalies. The effect of FA gene deficiency on hematopoietic development in utero remains poorly described as mouse models of FA do not develop hematopoietic failure and such studies cannot be performed on patients. We have created a human-specific in vitro system to study early hematopoietic development in FA using a lentiviral RNA interference (RNAi) strategy in human embryonic stem cells (hESCs). We show that knockdown of FANCA and FANCD2 in hESCs leads to a reduction in hematopoietic fates and progenitor numbers that can be rescued by FA gene complementation. Our data indicate that hematopoiesis is impaired in FA from the earliest stages of development, suggesting that deficiencies in embryonic hematopoiesis may underlie the progression to bone marrow failure in FA. This work illustrates how hESCs can provide unique insights into human development and further our understanding of genetic disease. (Blood. 2010; 115(17): 3453-3462)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available